Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M-Reference-Cited by-同舟云学术

Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M

Published:2020-01 Issue: Volume:121 Page:109601
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Aragó Marc,Moreno-Felici Juan,Abás Sonia^ORCID,Rodríguez-Arévalo Sergio,Hyroššová Petra^ORCID,Figueras Agnes,Viñals Francesc,Pérez Belén,Loza Maria I.,Brea Jose,Latorre Pedro,Carrodeguas Jose A.,García-Rovés Pablo M.,Galdeano Carlos,Ginex Tiziana^ORCID,Luque Francisco J.,Escolano Carmen,Perales Jose C.

Funder

Spanish “Ministerio de Economia y Competitividad”

Secretariat for Universities and Research of the Department of Business and Knowledge of the Government of Catalonia

“Ministerio de Educación” FPU

“Ministerio de Economia y Competitividad” (MINECO) FPI

Generalitat de Catalunya FI

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference25 articles.

1. The enzymatic carboxylation of phosphoenolpyruvate. II. Purification and properties of liver mitochondrial phosphoenolpyruvate carboxykinase;Chang;J. Biol. Chem.,1966